Boggan reports on AAIM
Post submitted by: Joel Boggan, MD, GIM Assistant Professor of Medicine and Associate Program Director in the Duke Internal M
Funding opp: Burroughs Wellcome Fund Research Technician RFA
The Office of Physician-Scientist Development is proud to announce the Burroughs Wellcome Fund (BWF) Research Technician RFA. Deadline for applications is May 15, 2019.
Jackson receives Duke REACH Equity Career Development Award
Larry Jackson II, MD, assistant professor of medicine (Cardiology), has received one of four 2019 Career Development Award from Duke REACH Equity Center.
DGIM Weekly eNews receives honorable mention from AAMC
The Division of General Internal Medicine at Duke is proud to announce their weekly DGIM eNewletter received Honorable Mention in the "Print and Digital Publishing - Internal Audience
Internal Medicine Residency News, April 15, 2019
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for April 15, 2019.
Jenny Van Kirk to take on new roles in residency program, undergraduate medical education
Jenny Van Kirk, MD, currently the chief medical resident for Duke University Hospital, will serve as the associate director of Undergraduate Medical Education (UME) for the Department of Medicine as well as assistant program director for the Internal Medicine Residency Program, effective July 1, 2019.
Rheumatic Diseases and Pregnancy: How do Outcomes Correlate to Patient-Reported Measures?
When a woman with rheumatic disease is pregnant, she may experience many symptoms--some from her underlying disease and some from pregnancy itself. Which of these symptoms signal increased risk for preterm delivery?
Nathaniel Harris, MD, PhD, an intern in the Duke internal medicine residency program, spent his third year of medical school, also at Duke, plumbing the DAP registry for insights into this question.
Rheumatic Diseases and Pregnancy: Should HCQ Dose Change in Pregnancy?
For women who take hydroxychloroquine (HCQ) to control rheumatic disease, research has shown that it’s best for mother and baby to continue the medicine during pregnancy. But should the dose be maintained, decreased, or increased? Stephen Balevic, MD, assistant professor of pediatrics and medicine (Rheumatology and Immunology), set out to investigate this question using data from the Duke Autoimmunity in Pregnancy registry.
2 faculty from the Department of Medicine inducted into AAP
Two Department Medicine faculty members were inducted into the Association of American Physicians (AAP) during a joint April 6 meeting of the AAP, the Ame